Vicore Pharma Holding AB
For the period ended Jul 6, 2026. Filed Jul 6, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jul 6, 2026 · Filed Jul 6, 2026
Use the contents to explore the available documents and sections.
VCRE$10.40+3.9%Stored close · as of Nov 6, 2026
Contents
Changes to Management
On July 6, 2026, Vicore Pharma Holding AB (the “Company”) issued a press release announcing the appointment of Rob Slack, PhD, FRSB to serve as the Company’s Chief Scientific Officer. The press release is attached as Exhibit 99.1 and is incorporated by reference herein.
| Exhibits | |
|---|---|
| 99.1 | Press Release, dated July 6, 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.